Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yi-Qin Luo"'
Publikováno v:
Oncology Reports
Oxaliplatin (Oxa)‑based chemotherapy is widely used as the first‑line treatment for colorectal cancer (CRC). However, Oxa‑resistance is common for many postoperative CRC patients. To explore drug resistance in CRC, an Oxa‑resistant cell line,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028e5d941cab0c06ed68ba3bccf1b4c9
http://europepmc.org/articles/PMC6775812
http://europepmc.org/articles/PMC6775812
Publikováno v:
Oncology Letters
Non-small cell lung cancer (NSCLC) is one of the most malignant cancer types. N6-methyladenosine (m6A), an abundant eukaryotic mRNA modification, has been observed in multiple diseases, particularly cancer. Methyltransferase-like 14 (METTL14) is a ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c70ca899ecac2a597446c5429e360cb
https://pubmed.ncbi.nlm.nih.gov/34733365
https://pubmed.ncbi.nlm.nih.gov/34733365
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Emerging evidence suggests the involvement of Reelin in chemoresistance in various cancers. However, its function in cisplatin (DDP) sensitivity of non-small cell lung cancer (NSCLC) needs to be investigated. MATERIAL AND METHODS Reelin ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14d2e1f38251456631334f371b371d48
https://doi.org/10.12659/msm.925298
https://doi.org/10.12659/msm.925298
Publikováno v:
Cellular Physiology and Biochemistry, Vol 48, Iss 6, Pp 2456-2469 (2018)
Background/Aims: The correlation between platelet levels and clinical outcomes has received increasing attention, but it is not yet clear whether and how platelet levels affect the therapeutic response in non-small cell lung cancer (NSCLC). In the cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b09a5d132339c2794b8c354ce543edfd
https://pubmed.ncbi.nlm.nih.gov/30121639
https://pubmed.ncbi.nlm.nih.gov/30121639
Publikováno v:
Transfusion. 54:2106-2117
Background Thrombocytopenia is a common side effect of tumor chemotherapy, the main management approach to which is based on platelet (PLT) transfusion. However, PLTs, containing angiogenesis regulators, play a major role in boosting tumor growth and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aaea0eb5c27aaa763abd883d9dd47cdf
https://doi.org/10.1111/trf.12617
https://doi.org/10.1111/trf.12617
Publikováno v:
Medical Science Monitor; 8/7/2020, Vol. 26, p1-11, 11p
Autor:
Yi-Qin Luo, Wen Hu, Jian-Ping Du, Li-Juan Yao, Zhou Ming, Liang Zhao, Hang Dong, Shuang-Zheng Wu
Publikováno v:
IUBMB Life. 64:423-431
Tumstatin is a candidate tumor suppressor that plays an important role in tumor growth and angiogenesis. The purpose of this study was to evaluate the correlation between tumstatin-mRNA expression and the clinicopathologic characteristics, tumor angi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd4deb05fdf24b481aaee3eaa886f939
https://doi.org/10.1002/iub.1016
https://doi.org/10.1002/iub.1016
Publikováno v:
Clinical and Experimental Medicine. 8:37-42
Tumstatin, a 28-kDa C-terminal fragment of collagen IV, is a potent anti-angiogenic protein and inhibitor of tumour growth. Recombinant tumstatin was prepared from Escherichia coli deposited as insoluble, inactive inclusion bodies. In the present stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7c81f55419ad23b0cd4ae1762e51d4
https://doi.org/10.1007/s10238-008-0154-2
https://doi.org/10.1007/s10238-008-0154-2
Autor:
Juan, Li, Jing, Luo, Yi-Qin, Luo, Ming, Zhou, Liang, Zhao, Li-Juan, Yao, Hang, Dong, Rui-Ning, Yang
Publikováno v:
Transfusion. 54(8)
Thrombocytopenia is a common side effect of tumor chemotherapy, the main management approach to which is based on platelet (PLT) transfusion. However, PLTs, containing angiogenesis regulators, play a major role in boosting tumor growth and metastasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ba18bc95c765a3ba271d28d6fc31cc0
https://pubmed.ncbi.nlm.nih.gov/24655355
https://pubmed.ncbi.nlm.nih.gov/24655355
Autor:
Jian-Ping Du, Wen Hu, Li-JuanYao, Shuang-Zheng Wu, Liang Zhao, Hang Dong, Yi-Qin Luo, An-yuan Sun
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 411(7-8)
Background Tumstatin, an angiogenesis inhibitor with anti-tumor activity in mice, is the bioactive NC1 domain of Col IVa3, the potential significance of tumstatin as an endogenous angiogenesis inhibitor in human is not yet completely understood. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da52b0105bc488e74a0c6160d9b50ad8
https://pubmed.ncbi.nlm.nih.gov/20064495
https://pubmed.ncbi.nlm.nih.gov/20064495